X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3939) 3939
Publication (262) 262
Book Review (190) 190
Newsletter (82) 82
Conference Proceeding (10) 10
Book Chapter (6) 6
Magazine Article (6) 6
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3528) 3528
animals (2032) 2032
cyclohexanes - pharmacology (1603) 1603
humans (1602) 1602
male (1098) 1098
rats (903) 903
cyclohexane (833) 833
pharmacology & pharmacy (811) 811
female (800) 800
mice (734) 734
cyclohexanes (652) 652
cyclohexanes - chemistry (365) 365
cyclohexanes - therapeutic use (356) 356
analysis (350) 350
chemistry, medicinal (340) 340
sesquiterpenes - pharmacology (323) 323
biochemistry & molecular biology (314) 314
time factors (306) 306
adult (286) 286
dose-response relationship, drug (284) 284
structure-activity relationship (273) 273
middle aged (254) 254
in vitro techniques (245) 245
cyclohexanes - administration & dosage (243) 243
phenylalanine - analogs & derivatives (236) 236
triazoles - pharmacology (235) 235
cyclohexanes - metabolism (225) 225
cyclohexanes - chemical synthesis (213) 213
hiv infections - drug therapy (213) 213
microbiology (197) 197
cell line (189) 189
expression (189) 189
cells, cultured (186) 186
toxicology (183) 183
maraviroc (182) 182
in-vitro (180) 180
oncology (180) 180
kinetics (179) 179
molecular structure (179) 179
research (179) 179
cancer (174) 174
cyclohexanes - pharmacokinetics (171) 171
nateglinide (170) 170
chemistry (163) 163
angiogenesis inhibitors - pharmacology (162) 162
hiv-1 - drug effects (150) 150
phenylalanine - pharmacology (149) 149
hypoglycemic agents - pharmacology (148) 148
triazoles - therapeutic use (148) 148
cells (147) 147
infectious diseases (147) 147
cell line, tumor (145) 145
ccr5 receptor antagonists (144) 144
stereoisomerism (144) 144
hiv (141) 141
rats, sprague-dawley (141) 141
angiogenesis (139) 139
chlorhexidine (138) 138
rabbits (137) 137
rats, wistar (135) 135
apoptosis (133) 133
chemical phenomena (132) 132
chemistry, organic (132) 132
antineoplastic agents - pharmacology (131) 131
dentistry (131) 131
fumagillin (131) 131
tnp-470 (127) 127
article (126) 126
cyclohexanes - toxicity (125) 125
cyclohexanes - adverse effects (123) 123
fatty acids, unsaturated - pharmacology (123) 123
aged (121) 121
chlorhexidine - pharmacology (121) 121
chemistry, multidisciplinary (119) 119
dogs (119) 119
drug interactions (118) 118
hiv infections - virology (118) 118
tumor-growth (117) 117
cyclohexenes (116) 116
abridged index medicus (115) 115
carbocyclic compounds (115) 115
immunology (115) 115
anti-bacterial agents - pharmacology (113) 113
disease models, animal (113) 113
antiviral agents (109) 109
enzyme inhibitors - pharmacology (109) 109
antibiotics, antineoplastic - pharmacology (108) 108
cell biology (108) 108
models, molecular (107) 107
mice, inbred c57bl (106) 106
microbial sensitivity tests (106) 106
anti-hiv agents - pharmacology (104) 104
cell division - drug effects (104) 104
dentistry, oral surgery & medicine (104) 104
neurosciences (104) 104
administration, oral (103) 103
protein binding (102) 102
inhibition (101) 101
virology (99) 99
guinea pigs (98) 98
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3633) 3633
German (125) 125
Japanese (117) 117
French (52) 52
Russian (23) 23
Italian (20) 20
Spanish (19) 19
Chinese (16) 16
Polish (10) 10
Slovak (6) 6
Czech (5) 5
Danish (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmacological Research, ISSN 1043-6618, 09/2012, Volume 66, Issue 3, pp. 251 - 259
Endocannabinoids exhibit vasodilatory properties and reduce blood pressure . However, the influence and mechanism of action of the prominent endocannabinoid,... 
Endocannabinoid | Abnormal cannabidiol | Pulmonary artery | Anandamide | Endothelium | VIRODHAMINE | VASORELAXATION | SMALL MESENTERIC-ARTERY | CANNABINOID RECEPTOR | VESSELS | VASCULATURE | RESISTANCE | PHARMACOLOGY & PHARMACY | CHANNELS | HYPERTENSION | ABNORMAL-CANNABIDIOL | Tetraethylammonium - pharmacology | Endocannabinoids - pharmacology | Rats, Wistar | Capsaicin - pharmacology | Anisoles - pharmacology | Cyclohexanes - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Endothelium, Vascular - drug effects | Male | Apamin - pharmacology | Receptors, Cannabinoid - metabolism | TRPV Cation Channels - metabolism | Piperidines - pharmacology | Charybdotoxin - pharmacology | TRPV Cation Channels - antagonists & inhibitors | Potassium Chloride - metabolism | Cannabinoid Receptor Antagonists - pharmacology | Indoles - pharmacology | Benzamides - pharmacology | Potassium Channel Blockers - pharmacology | Carbamates - pharmacology | Pyrazoles - pharmacology | Amidohydrolases - metabolism | NG-Nitroarginine Methyl Ester - pharmacology | Receptors, Epoprostenol - metabolism | Rats | Amidohydrolases - antagonists & inhibitors | Capsaicin - analogs & derivatives | Imidazoles - pharmacology | Pulmonary Artery - drug effects | Arachidonic Acids - pharmacology | Indomethacin - pharmacology | Receptors, Epoprostenol - antagonists & inhibitors | Animals | Benzyl Compounds - pharmacology | Endothelium, Vascular - metabolism | Prostaglandin-Endoperoxide Synthases - metabolism | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology | Polyunsaturated Alkamides - pharmacology | Nitric Oxide Synthase - metabolism | Vasodilation - drug effects | Hypertension | Enzymes | Vasodilators | Blood vessels | Glycerol | Fatty acids | Pulmonary hypertension | Glycerin | Cannabinoids | Dilatation | Dimethyl sulfoxide | Hydrolases | Indomethacin | Index Medicus
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2017, Volume 794, pp. 209 - 215
N-arachidonoyl glycine (NAGLY), is the endogenous lipid that activates the G protein-couple receptor 18 (GPR18) with vasodilatory activity in resistance... 
Na+/Ca2+ exchanger | Vasorelaxation | Nitric oxide | N-arachidonoyl glycine | Hypotensive | Ca | exchanger | ANANDAMIDE-INDUCED VASORELAXATION | RAT | IDENTIFICATION | VASCULAR ENDOTHELIUM | CORONARY-ARTERIES | SMALL MESENTERIC-ARTERY | CANNABINOID RECEPTOR | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | ABNORMAL-CANNABIDIOL | GPR18 | Glycine - analogs & derivatives | Kidney - blood supply | Rats, Wistar | Capsaicin - pharmacology | Anisoles - pharmacology | Cyclohexanes - pharmacology | Endothelium, Vascular - drug effects | Male | Thiourea - pharmacology | Quinoxalines - pharmacology | Phenylephrine - pharmacology | Regional Blood Flow - drug effects | Piperidines - pharmacology | Oxadiazoles - pharmacology | Blood Pressure - drug effects | Pyrazoles - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Kidney - drug effects | Rats | Capsaicin - analogs & derivatives | Arachidonic Acids - pharmacology | Hypertension - physiopathology | Hypertension - metabolism | Carbachol - pharmacology | Animals | Cyclic GMP - metabolism | Glycine - pharmacology | Endothelium, Vascular - metabolism | Anilides - pharmacology | Endothelium, Vascular - pathology | Potassium Channels, Calcium-Activated - antagonists & inhibitors | Vasodilation - drug effects | Nitric Oxide - metabolism | Thiourea - analogs & derivatives | Medical colleges | Dilatation | Vasodilators | Blood vessels | Indomethacin | Glycine | Endothelium | Index Medicus
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2007, Volume 150, Issue 5, pp. 613 - 623
Background and purpose: A nonpsychoactive constituent of the cannabis plant, cannabidiol has been demonstrated to have low affinity for both cannabinoid CB1... 
cannabidiol | CP55940 | S assay | GTP | O‐2654 | receptor | mouse brain | inverse agonism | neutral antagonism | CB2 receptor | O-2654 | GTP gamma S assay | INHIBITION | LIGANDS | CB1 receptor | SELECTIVE INVERSE AGONIST | MOUSE VAS-DEFERENS | PERIPHERAL CANNABINOID RECEPTOR | PHARMACOLOGY & PHARMACY | BINDING | BRAIN | Cricetulus | Cyclohexanols | Receptor, Cannabinoid, CB2 - agonists | Cannabinoid Receptor Antagonists | Cyclohexanes - pharmacology | Humans | Bornanes - pharmacology | Anti-Inflammatory Agents - metabolism | Brain - metabolism | Dose-Response Relationship, Drug | Receptors, Cannabinoid - metabolism | Receptor, Cannabinoid, CB1 - agonists | Transfection | Piperidines - pharmacology | Morpholines - antagonists & inhibitors | Phenols - antagonists & inhibitors | Cyclohexanes - antagonists & inhibitors | Benzoxazines - antagonists & inhibitors | Cell Membrane - metabolism | Cell Membrane - drug effects | Receptors, Cannabinoid - genetics | CHO Cells | Phenols - pharmacology | Pyrazoles - pharmacology | Cricetinae | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Morpholines - pharmacology | Cannabidiol - pharmacology | Mice, Knockout | Naphthalenes - pharmacology | Brain - drug effects | Cannabinoid Receptor Agonists | Guanosine 5'-O-(3-Thiotriphosphate) - metabolism | Animals | Benzoxazines - pharmacology | Protein Binding | Mice | Cannabidiol - metabolism | In Vitro Techniques | Naphthalenes - antagonists & inhibitors | Index Medicus | Research Papers | GTPγS assay
Journal Article
Molecular Pharmacology, ISSN 0026-895X, 03/2008, Volume 73, Issue 3, pp. 789 - 800
In addition to being an important receptor in leukocyte activation and mobilization, CCR5 is the essential coreceptor for human immunodeficiency virus (HIV). A... 
AMINO-TERMINAL DOMAIN | PROTEIN | ENTRY | CORECEPTOR | RECEPTOR ANTAGONISTS | IMMUNODEFICIENCY-VIRUS TYPE-1 | ANTI-HIV-1 ACTIVITY | PHARMACOLOGY & PHARMACY | HIGHLY POTENT | INHIBITOR | BINDING | Anti-HIV Agents - pharmacology | Benzoates - metabolism | Humans | Receptors, CCR5 - genetics | Piperazines - chemistry | Pyrimidines - metabolism | Receptors, CCR5 - metabolism | Piperidines - pharmacology | Amides - metabolism | Anti-HIV Agents - metabolism | Radioligand Assay | Binding Sites | Amides - pharmacology | Anti-HIV Agents - classification | Amino Acid Sequence | Piperidines - metabolism | Models, Molecular | Pyrimidines - pharmacology | HIV Fusion Inhibitors - pharmacology | Piperazines - pharmacology | Triazoles - metabolism | Anti-HIV Agents - chemistry | Amides - chemistry | Benzoates - pharmacology | Hydrophobic and Hydrophilic Interactions | Receptors, CCR5 - chemistry | Quaternary Ammonium Compounds - pharmacology | Cricetulus | Triazoles - chemistry | Benzoates - chemistry | Cyclohexanes - pharmacology | Molecular Sequence Data | Piperazines - metabolism | Quaternary Ammonium Compounds - chemistry | Pyrimidines - chemistry | Cyclohexanes - metabolism | Transfection | Inhibitory Concentration 50 | Cyclohexanes - chemistry | Molecular Structure | Membrane Fusion - drug effects | Spiro Compounds - chemistry | CCR5 Receptor Antagonists | CHO Cells | Protein Structure, Tertiary | Cricetinae | Piperidines - chemistry | Mutagenesis, Site-Directed | Protein Structure, Secondary | HIV-1 - drug effects | Static Electricity | Sequence Homology, Amino Acid | Triazoles - pharmacology | Animals | Quaternary Ammonium Compounds - metabolism | Spiro Compounds - pharmacology | Spiro Compounds - metabolism | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, pp. e0148242 - e0148242
Annual losses of honey bee colonies remain high and pesticide exposure is one possible cause. Dangerous combinations of pesticides, plant-produced compounds... 
MALPIGHIAN TUBULES | DRUG INTERACTIONS | APIS-MELLIFERA | GLYCOPROTEIN-MEDIATED TRANSPORT | MULTIDISCIPLINARY SCIENCES | INSECTICIDE TOXICITY | IVERMECTIN | ABC TRANSPORTERS | EXPRESSION | P-GLYCOPROTEIN | TRANSEPITHELIAL TRANSPORT | Niacinamide - analogs & derivatives | Drug Resistance, Multiple | Cyclohexanes - pharmacology | Neonicotinoids | Rhodamines - metabolism | Ivermectin - metabolism | Biphenyl Compounds - pharmacology | Membrane Transport Proteins - metabolism | Biological Transport - drug effects | Carbamates - pharmacology | Pyrazoles - pharmacology | Insecticides - pharmacology | Risk Assessment | Fatty Acids, Unsaturated - pharmacology | Ivermectin - pharmacology | Verapamil - pharmacology | Environmental Exposure - adverse effects | Animals | Quercetin - pharmacology | ATP-Binding Cassette Transporters - drug effects | Bees - drug effects | Pyridines - pharmacology | Niacinamide - pharmacology | Sesquiterpenes - pharmacology | ATP-Binding Cassette Transporters - antagonists & inhibitors | Honeybee | Research | Drug resistance | Health aspects | Ivermectin | Rhodamine | Laboratories | Fluorescence | Insecticides | Biochemistry | Parasites | Tissues | Bees | Proteins | Toxicology | Insecticide resistance | Agrochemicals | Metabolites | Risk assessment | Physiology | Agriculture | Enzymes | Colonies | Multidrug resistance | Pesticides | Hemolymph | Substrate inhibition | Metabolism | Chemicals | Honey | Sensitivity | Antibiotics | Insects | Animal behavior | Quercetin | Strategy | Chemical interactions | Verapamil | In vivo methods and tests | Molecular biology | Transporter | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2013, Volume 57, Issue 5, pp. 2076 - 2086
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
TRANSIENT EXPRESSION | FC-RECEPTOR | HIV-1 ENVELOPE | CD4-BINDING SITE | RAPID PRODUCTION | IMMUNODEFICIENCY-VIRUS TYPE-1 | NONNEUTRALIZING ANTIBODIES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SHIV CHALLENGE | CELL | RATIONAL DESIGN | Antibodies, Monoclonal - biosynthesis | Antiviral Agents - immunology | Cyclohexanes - pharmacology | Humans | HIV Envelope Protein gp120 - antagonists & inhibitors | Neutralization Tests | Antiviral Agents - metabolism | Recombinant Proteins - biosynthesis | HIV Envelope Protein gp120 - metabolism | Tenofovir | Antibodies, Neutralizing - immunology | HIV-1 - growth & development | Tobamovirus - genetics | HIV Antibodies - immunology | Immunoglobulin G - biosynthesis | Immunoglobulin G - immunology | HIV Antibodies - biosynthesis | Immunoglobulin G - pharmacology | HIV Antibodies - pharmacology | Antibodies, Monoclonal - immunology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | Antibodies, Neutralizing - pharmacology | Plant Lectins - pharmacology | Adenine - pharmacology | Recombinant Proteins - pharmacology | Drug Synergism | Triazoles - pharmacology | Organophosphonates - pharmacology | Animals | Chromatography, Affinity | Recombinant Proteins - immunology | Antibodies, Neutralizing - biosynthesis | Tobacco - genetics | Genetic Vectors | Drug Combinations | Index Medicus | Antiviral Agents
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2013, Volume 33, Issue 14, pp. 5881 - 5894
Pain is a complex experience composed of sensory and affective components. Although the neural systems of the sensory component of pain have been studied... 
MESSENGER-RNAS | NONSELECTIVE CATIONIC CONDUCTANCE | ANTERIOR CINGULATE CORTEX | BASOLATERAL AMYGDALA | INDUCED AVERSION | MIDBRAIN DOPAMINE NEURONS | MORPHINE-WITHDRAWAL | DIFFERENTIAL DISTRIBUTION | CRF RECEPTORS | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | Septal Nuclei - drug effects | Cyclohexanes - pharmacology | Septal Nuclei - physiology | Male | Peptide Fragments - pharmacology | Hormones - adverse effects | Pain - chemically induced | Pyridazines - pharmacology | Septal Nuclei - cytology | Arginine - analogs & derivatives | Affective Symptoms - etiology | Pain - complications | Hormones - agonists | Corticotropin-Releasing Hormone - antagonists & inhibitors | Kynurenic Acid - pharmacology | Neuropeptide Y - agonists | Formaldehyde - toxicity | Neurons - drug effects | Neuropeptide Y - antagonists & inhibitors | Action Potentials - drug effects | Xanthenes - pharmacology | Disease Models, Animal | Membrane Potentials - drug effects | Aniline Compounds - pharmacology | Corticotropin-Releasing Hormone - adverse effects | Neuropeptide Y - therapeutic use | Rats | Corticotropin-Releasing Hormone - agonists | Excitatory Amino Acid Antagonists - pharmacology | Pyrimidines - pharmacology | Rats, Sprague-Dawley | GABA Antagonists - pharmacology | Hormone Antagonists - pharmacology | Affective Symptoms - drug therapy | Animals | Microdialysis | Analysis of Variance | Arginine - pharmacology | In Vitro Techniques | Pain Measurement | Index Medicus
Journal Article
Nature Immunology, ISSN 1529-2908, 2014, Volume 15, Issue 8, pp. 717 - 726
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2013, Volume 57, Issue 9, pp. 4172 - 4180
Journal Article
Psychopharmacology, ISSN 0033-3158, 6/2013, Volume 227, Issue 4, pp. 711 - 725
Journal Article
Neuropharmacology, ISSN 0028-3908, 09/2018, Volume 140, pp. 246 - 259
Group II metabotropic glutamate receptors (mGluR2 and mGluR3) are implicated in a number of psychiatric disorders. They also control sleep-wake architecture... 
Sleep | EEG | mGluR2 | Hyperlocomotion | Metabotropic glutamate receptor | Han Wistar | mGluR3 | AGONIST LY379268 | HIGH-FREQUENCY OSCILLATIONS | LOCOMOTOR-ACTIVITY | METABOTROPIC GLUTAMATE RECEPTORS | G-PROTEIN | NEUROSCIENCES | PREFRONTAL CORTEX | NUCLEUS-ACCUMBENS | PHENCYCLIDINE | PSYCHIATRIC-DISORDERS | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Theta Rhythm - drug effects | Motor Activity - physiology | Phencyclidine - pharmacology | Wakefulness - drug effects | Cyclohexanes - pharmacology | Motor Activity - drug effects | Receptors, Metabotropic Glutamate - physiology | Male | Amino Acids - pharmacology | Dose-Response Relationship, Drug | Receptors, Metabotropic Glutamate - genetics | Sleep - physiology | Receptors, Metabotropic Glutamate - deficiency | Locomotion - drug effects | Theta Rhythm - physiology | Phencyclidine - antagonists & inhibitors | Gamma Rhythm - drug effects | Bridged Bicyclo Compounds - pharmacology | Amphetamine - pharmacology | Rats | Excitatory Amino Acid Agonists - pharmacology | Gamma Rhythm - physiology | Sleep - drug effects | Amphetamine - antagonists & inhibitors | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Wakefulness - physiology | Antipsychotic Agents - pharmacology | Mutation | Locomotion - physiology | Architecture | Glutamate | Mental illness | Investigations | Index Medicus | EEG, electroencephalography | mGluR3, metabotropic glutamate receptor 3 | mGluR2, metabotropic glutamate receptor 2 | Grm2, glutamate receptor metabotropic 2 | HFO, high frequency oscillations
Journal Article